A detailed history of Ikarian Capital, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 40,369 shares of RLMD stock, worth $15,340. This represents 0.02% of its overall portfolio holdings.

Number of Shares
40,369
Previous 40,369 -0.0%
Holding current value
$15,340
Previous $121,000 7.44%
% of portfolio
0.02%
Previous 0.05%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$2.48 - $3.79 $62,302 - $95,212
-25,122 Reduced 38.36%
40,369 $121,000
Q4 2022

Feb 14, 2023

BUY
$2.17 - $35.84 $142,115 - $2.35 Million
65,491 New
65,491 $228,000
Q1 2022

May 13, 2022

BUY
$16.72 - $26.99 $17,689 - $28,555
1,058 Added 5.1%
21,801 $588,000
Q3 2021

Nov 15, 2021

SELL
$21.86 - $34.77 $6.11 Million - $9.72 Million
-279,464 Reduced 93.09%
20,743 $544,000
Q2 2021

Aug 16, 2021

BUY
$29.55 - $39.15 $295,500 - $391,500
10,000 Added 3.45%
300,207 $9.61 Million
Q1 2021

May 17, 2021

BUY
$31.52 - $39.28 $9.15 Million - $11.4 Million
290,207 New
290,207 $10.2 Million
Q2 2020

Aug 14, 2020

SELL
$31.59 - $49.98 $1.74 Million - $2.76 Million
-55,172 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$23.78 - $50.12 $1.31 Million - $2.77 Million
55,172 New
55,172 $1.88 Million

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.